SARS-CoV-2 Omicron variant emerged under immune selection

Nat Microbiol. 2022 Nov;7(11):1756-1761. doi: 10.1038/s41564-022-01246-1. Epub 2022 Oct 4.

Abstract

The SARS-CoV-2 Omicron variant (B.1.1.529 lineage) escapes antibodies that neutralize the ancestral virus. We tested human serum panels from participants with differing infection and vaccination status using a multiplex surrogate virus neutralization assay targeting 20 sarbecoviruses. We found that bat and pangolin sarbecoviruses showed significantly less neutralization escape than the Omicron variant. We propose that SARS-CoV-2 variants have emerged under immune selection pressure and are evolving differently from animal sarbecoviruses.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral
  • COVID-19*
  • Humans
  • Membrane Glycoproteins
  • Neutralization Tests
  • SARS-CoV-2* / genetics
  • Spike Glycoprotein, Coronavirus / genetics
  • Viral Envelope Proteins

Substances

  • Spike Glycoprotein, Coronavirus
  • Viral Envelope Proteins
  • Antibodies, Viral
  • Membrane Glycoproteins
  • spike protein, SARS-CoV-2

Supplementary concepts

  • SARS-CoV-2 variants